» Authors » G Smets

G Smets

Explore the profile of G Smets including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 272
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Smets G, Gutermuth J, Grosber M, Baharlou S
J Eur Acad Dermatol Venereol . 2023 Oct; 38(3):e229-e230. PMID: 37793828
No abstract available.
2.
Smets G, Grosber M, Gutermuth J, Bravenboer B, Velkeniers B
J Eur Acad Dermatol Venereol . 2021 Mar; 35(7):e462-e464. PMID: 33725368
No abstract available.
3.
Verhelst J, Klaes R, Smets G, Kloppel G, Hoorens A, Abs R, et al.
Endocr Pathol . 2020 May; 3(4):205-208. PMID: 32370426
The pathological findings are described of a female patient with persistent Cushing's disease after two unsuccessful transsphenoidal operations: a left transsphenoidal hemihypophysectomy followed by a total hypophysectomy 1 month later....
4.
Smets G, Alcalde E, Andres D, Carron D, Delzenne P, Heise A, et al.
Environ Sci Process Impacts . 2014 May; 16(7):1754-63. PMID: 24836113
The European Union (EU) Directive 2001/18/EC on the deliberate release of genetically modified organisms (GMOs) into the environment requires that both Case-Specific Monitoring (CSM) and General Surveillance (GS) are considered...
5.
Van Driessche E, Smets G, Dejaegere R, Kanarek L
Planta . 2013 Nov; 153(4):287-96. PMID: 24276930
The lectin from the garden pea (Pisum sativum L.) has been localized at the ultrastructural level by the unlabeled peroxidase-antiperoxidase procedure of L.A. Sternberger et al. (1970, J. Histochem. Cytochem...
6.
End D, Smets G, Todd A, Applegate T, Fuery C, Angibaud P, et al.
Cancer Res . 2001 Feb; 61(1):131-7. PMID: 11196150
R115777 [(B)-6-[amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)-methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone] is a potent and selective inhibitor of farnesyl protein transferase with significant antitumor effects in vivo subsequent to oral administration in mice. In vitro, using isolated human farnesyl...
7.
Van Heusden J, Wouters W, Ramaekers F, Krekels M, Dillen L, Borgers M, et al.
Br J Cancer . 1998 May; 77(8):1229-35. PMID: 9579827
The clinical use of all-trans-retinoic acid (ATRA) in the treatment of cancer is significantly hampered by the prompt emergence of resistance, believed to be caused by increased ATRA catabolism. Inhibitors...
8.
Van Heusden J, Wouters W, Ramaekers F, Krekels M, Dillen L, Borgers M, et al.
Br J Cancer . 1998 Feb; 77(1):26-32. PMID: 9459142
All-trans-retinoic acid (ATRA) is well known to inhibit the proliferation of human breast cancer cells. Much less is known about the antiproliferative activity of the naturally occurring metabolites and isomers...
9.
Abs R, Smets G, Vauquelin G, Verhelst J, Mahler C, Verlooy J, et al.
Neurochem Int . 1997 Mar; 30(3):291-7. PMID: 9041560
The presence of corticotropin-releasing hormone (CRH) receptors has been previously demonstrated in corticotrophs from normal pituitaries using a method combining immunocytochemistry and liquid emulsion autoradiography. The aim of this study...
10.
Van Heusden J, de Jong P, Ramaekers F, Bruwiere H, Borgers M, Smets G
J Histochem Cytochem . 1997 Feb; 45(2):315-9. PMID: 9016320
Immunocytochemical detection of bromodeoxyuridine (BrdU) labeling can be hampered by low BrdU incorporation levels. We describe here an amplification method for weak BrdU immunosignals. The tyramide signal amplification method based...